vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and EXPRO GROUP HOLDINGS N.V. (XPRO). Click either name above to swap in a different company.

EXPRO GROUP HOLDINGS N.V. is the larger business by last-quarter revenue ($382.1M vs $138.3M, roughly 2.8× Core Laboratories Inc.). Core Laboratories Inc. runs the higher net margin — 3.6% vs 1.5%, a 2.1% gap on every dollar of revenue. On growth, Core Laboratories Inc. posted the faster year-over-year revenue change (7.0% vs -12.5%). EXPRO GROUP HOLDINGS N.V. produced more free cash flow last quarter ($23.2M vs $5.0M). Over the past eight quarters, Core Laboratories Inc.'s revenue compounded faster (3.3% CAGR vs -0.2%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Expro is an energy services provider headquartered in Houston, Texas, United States.

CLB vs XPRO — Head-to-Head

Bigger by revenue
XPRO
XPRO
2.8× larger
XPRO
$382.1M
$138.3M
CLB
Growing faster (revenue YoY)
CLB
CLB
+19.5% gap
CLB
7.0%
-12.5%
XPRO
Higher net margin
CLB
CLB
2.1% more per $
CLB
3.6%
1.5%
XPRO
More free cash flow
XPRO
XPRO
$18.2M more FCF
XPRO
$23.2M
$5.0M
CLB
Faster 2-yr revenue CAGR
CLB
CLB
Annualised
CLB
3.3%
-0.2%
XPRO

Income Statement — Q4 2025 vs Q4 2025

Metric
CLB
CLB
XPRO
XPRO
Revenue
$138.3M
$382.1M
Net Profit
$4.9M
$5.8M
Gross Margin
20.8%
Operating Margin
11.5%
3.1%
Net Margin
3.6%
1.5%
Revenue YoY
7.0%
-12.5%
Net Profit YoY
-33.2%
-74.9%
EPS (diluted)
$0.11
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
XPRO
XPRO
Q4 25
$138.3M
$382.1M
Q3 25
$134.5M
$411.4M
Q2 25
$130.2M
$422.7M
Q1 25
$123.6M
$390.9M
Q4 24
$129.2M
$436.8M
Q3 24
$134.4M
$422.8M
Q2 24
$130.6M
$469.6M
Q1 24
$129.6M
$383.5M
Net Profit
CLB
CLB
XPRO
XPRO
Q4 25
$4.9M
$5.8M
Q3 25
$14.2M
$14.0M
Q2 25
$10.6M
$18.0M
Q1 25
$-154.0K
$13.9M
Q4 24
$7.4M
$23.0M
Q3 24
$11.7M
$16.3M
Q2 24
$9.0M
$15.3M
Q1 24
$3.2M
$-2.7M
Gross Margin
CLB
CLB
XPRO
XPRO
Q4 25
20.8%
Q3 25
22.0%
Q2 25
20.3%
Q1 25
19.5%
Q4 24
17.8%
Q3 24
20.5%
Q2 24
21.2%
Q1 24
19.3%
Operating Margin
CLB
CLB
XPRO
XPRO
Q4 25
11.5%
3.1%
Q3 25
15.6%
6.4%
Q2 25
11.7%
7.7%
Q1 25
3.6%
2.6%
Q4 24
11.0%
7.3%
Q3 24
14.7%
6.2%
Q2 24
12.3%
5.9%
Q1 24
6.6%
2.2%
Net Margin
CLB
CLB
XPRO
XPRO
Q4 25
3.6%
1.5%
Q3 25
10.6%
3.4%
Q2 25
8.2%
4.3%
Q1 25
-0.1%
3.6%
Q4 24
5.7%
5.3%
Q3 24
8.7%
3.8%
Q2 24
6.9%
3.3%
Q1 24
2.5%
-0.7%
EPS (diluted)
CLB
CLB
XPRO
XPRO
Q4 25
$0.11
$0.05
Q3 25
$0.30
$0.12
Q2 25
$0.22
$0.16
Q1 25
$0.00
$0.12
Q4 24
$0.15
$0.20
Q3 24
$0.25
$0.14
Q2 24
$0.19
$0.13
Q1 24
$0.07
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
XPRO
XPRO
Cash + ST InvestmentsLiquidity on hand
$22.7M
$196.1M
Total DebtLower is stronger
$110.3M
$79.1M
Stockholders' EquityBook value
$266.0M
$1.5B
Total Assets
$584.0M
$2.3B
Debt / EquityLower = less leverage
0.41×
0.05×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
XPRO
XPRO
Q4 25
$22.7M
$196.1M
Q3 25
$25.6M
$197.9M
Q2 25
$31.2M
$206.8M
Q1 25
$22.1M
$179.3M
Q4 24
$19.2M
$183.0M
Q3 24
$21.5M
$165.7M
Q2 24
$17.7M
$133.5M
Q1 24
$14.9M
$163.2M
Total Debt
CLB
CLB
XPRO
XPRO
Q4 25
$110.3M
$79.1M
Q3 25
$114.1M
$99.1M
Q2 25
$124.6M
$121.1M
Q1 25
$124.4M
$121.1M
Q4 24
$126.1M
$121.1M
Q3 24
$139.9M
$121.1M
Q2 24
$147.6M
$121.1M
Q1 24
$160.4M
$40.0M
Stockholders' Equity
CLB
CLB
XPRO
XPRO
Q4 25
$266.0M
$1.5B
Q3 25
$271.3M
$1.5B
Q2 25
$261.3M
$1.5B
Q1 25
$253.4M
$1.5B
Q4 24
$246.6M
$1.5B
Q3 24
$250.7M
$1.5B
Q2 24
$240.3M
$1.5B
Q1 24
$232.2M
$1.3B
Total Assets
CLB
CLB
XPRO
XPRO
Q4 25
$584.0M
$2.3B
Q3 25
$591.4M
$2.3B
Q2 25
$602.1M
$2.3B
Q1 25
$591.5M
$2.3B
Q4 24
$585.1M
$2.3B
Q3 24
$600.5M
$2.3B
Q2 24
$597.8M
$2.3B
Q1 24
$597.8M
$2.0B
Debt / Equity
CLB
CLB
XPRO
XPRO
Q4 25
0.41×
0.05×
Q3 25
0.42×
0.07×
Q2 25
0.48×
0.08×
Q1 25
0.49×
0.08×
Q4 24
0.51×
0.08×
Q3 24
0.56×
0.08×
Q2 24
0.61×
0.08×
Q1 24
0.69×
0.03×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
XPRO
XPRO
Operating Cash FlowLast quarter
$7.9M
$57.1M
Free Cash FlowOCF − Capex
$5.0M
$23.2M
FCF MarginFCF / Revenue
3.6%
6.1%
Capex IntensityCapex / Revenue
2.1%
8.9%
Cash ConversionOCF / Net Profit
1.61×
9.89×
TTM Free Cash FlowTrailing 4 quarters
$25.8M
$97.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
XPRO
XPRO
Q4 25
$7.9M
$57.1M
Q3 25
$8.5M
$63.2M
Q2 25
$13.9M
$48.4M
Q1 25
$6.7M
$41.5M
Q4 24
$20.6M
$97.4M
Q3 24
$13.1M
$55.3M
Q2 24
$17.1M
$-13.2M
Q1 24
$5.5M
$29.9M
Free Cash Flow
CLB
CLB
XPRO
XPRO
Q4 25
$5.0M
$23.2M
Q3 25
$6.5M
$39.0M
Q2 25
$10.4M
$27.2M
Q1 25
$3.9M
$8.4M
Q4 24
$17.4M
$53.0M
Q3 24
$10.4M
$23.3M
Q2 24
$14.3M
$-49.5M
Q1 24
$2.5M
$-801.0K
FCF Margin
CLB
CLB
XPRO
XPRO
Q4 25
3.6%
6.1%
Q3 25
4.8%
9.5%
Q2 25
8.0%
6.4%
Q1 25
3.1%
2.1%
Q4 24
13.4%
12.1%
Q3 24
7.7%
5.5%
Q2 24
10.9%
-10.5%
Q1 24
1.9%
-0.2%
Capex Intensity
CLB
CLB
XPRO
XPRO
Q4 25
2.1%
8.9%
Q3 25
1.5%
5.9%
Q2 25
2.7%
5.0%
Q1 25
2.3%
8.5%
Q4 24
2.5%
10.2%
Q3 24
2.0%
7.6%
Q2 24
2.2%
7.7%
Q1 24
2.4%
8.0%
Cash Conversion
CLB
CLB
XPRO
XPRO
Q4 25
1.61×
9.89×
Q3 25
0.60×
4.52×
Q2 25
1.31×
2.69×
Q1 25
2.98×
Q4 24
2.78×
4.23×
Q3 24
1.12×
3.40×
Q2 24
1.90×
-0.86×
Q1 24
1.72×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLB
CLB

Services$107.0M77%
Products$31.3M23%

XPRO
XPRO

NLA$130.3M34%
ESSA$116.3M30%
MENA$93.0M24%
Other$42.5M11%

Related Comparisons